Articles
Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?
Citation:
European Cardiology Review 2017;12(2):103.
A Transcriptional Co-activator, p300 is Involved in the Epigenetic Gene Activation on Hypertrophic Response Gene Promoters in Heart Failure
Citation:
European Cardiology Review 2017;12(2):110.
Differences in Clinical Characteristics, Results and Management of Patients Referred for Pharmacologic Cardiac Stress SPECT Depending on the Protocol Used
Citation:
European Cardiology Review 2017;12(2):102.
Consensus is Possible: Initiation and Exchange of Oral Anticoagulants in Non-valvular Atrial Fibrillation, According to a Territorial Protocol in a Period of Time
Citation:
European Cardiology Review 2017;12(2):104.
A Novel Target Molecule of Nobiletin Derived from Citrus Peels has a Therapeutic Potency Against the Development of Heart Failure
Citation:
European Cardiology Review 2017;12(2):105.
Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo
Citation:
European Cardiology Review 2017;12(2):106.
Prospective and Centralized Follow-Up of a Territorial Protocol of Use of Direct Oral Anticoagulants in Non Valvular Atrial Fibrillation
Citation:
European Cardiology Review 2017;12(2):108.
Analysis of Factors Associated with Smoking Relapse
Citation:
European Cardiology Review 2017;12(2):111.
Choice of Anticoagulation Therapy in Atrial Patients with Rate Control and Rhythm Control Strategy - Data from a Multicenter Real-life Registry
Citation:
European Cardiology Review 2017;12(2):109.